Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Yesterday, Embraer S.A. ( ERJ - Analyst Report ) along with The Boeing Company ( BA - Analyst Report ) announced an agreement, which tied the two big banners of global aviation in a strategic relationship. The mutual partnership is aimed to foster operational efficiency and customer satisfaction, without compromising safety and productivity.
Brazilian and United States governments signed a Memorandum of Understanding (MoU) on the Aviation Partnership, targeted to pursue several areas of cooperation, including research, technology and sustainable aviation biofuels—a stride quite enviable to Embraer’s peers such as Lockheed Martin Corporation ( LMT - Analyst Report ) and Northrop Grumman Corporation ( NOC - Analyst Report ) .
Frederico Curado, President and CEO of Embraer S.A, expressed his optimism about this public-private partnership between the two nations, which he said would strengthen their national ties on civil aviation platform.
Co-operative agreements between these two nations are not new to the world. Looking back the records, Boeing and Embraer had announced plans in July 2011 to jointly produce sustainable aviation jet fuel from sugarcane.
Later, in March 2012, global aviation industry witnessed the two aviators sign a MoU with Airbus to work together on the development of affordable aviation bio-fuels.
Riding the optimistic wave, both these partners foresee opportunities to reduce customers' operational costs and enhance fleet efficiency. Embraer’s corporate presence in the U.S. for over 3 decades and Boeing’s enduring partnership with Brazil for over 80 years reinforce the partnership spirit.
We are currently holding a long-term Neutral recommendation on Embraer. Also, Embraer has a Zacks #3 Rank, which translates into a short-term (1-3 months) Hold rating.
Read the full reports :
Analyst Report on NOC
Analyst Report on ERJ
Analyst Report on BA
Analyst Report on LMT